TMPRSS15
protein-codingtransmembrane serine protease 15, the group of Type II transmembrane serine proteases|Scavenger receptor cysteine rich domain containing
Gene summary
This gene encodes an enzyme that converts the pancreatic proenzyme trypsinogen to trypsin, which activates other proenzymes including chymotrypsinogen and procarboxypeptidases. The precursor protein is cleaved into two chains that form a heterodimer linked by a disulfide bond. This protein is a member of the trypsin family of peptidases. Mutations in this gene cause enterokinase deficiency, a malabsorption disorder characterized by diarrhea and failure to thrive. [provided by RefSeq, Jul 2008]
- PRSS7
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~216.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0009173
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0009173
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0009173
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009173
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Gastrointestinal
Intervention: Gastrointestinal
Rationale: The condition tends to self-resolve, but early in life, pancreatic enzyme replacement or hydrolyzed formula can be beneficial
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TMPRSS15 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_002772.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 142 | 3 | 147 | ||
| missense | 2 | 244 | 27 | 9 | 282 | |
| nonsense | 25 | 5 | 2 | 32 | ||
| start loss | 0 | |||||
| frameshift | 23 | 10 | 33 | |||
| splice donor/acceptor (+/-2bp) | 25 | 1 | 26 | |||
| Total | 48 | 42 | 249 | 169 | 12 | 520 |
Highest pathogenic variant AF is 0.0013315126
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_002763.3 | 25 | MANE Select | |
| Ensembl | ENSP00000284885.3 | 25 | MANE Select | |
| RefSeq | NP_001414985.1 | 27 | Standard | |
| RefSeq | NP_001414986.1 | 25 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- proteolysis
- receptor-mediated endocytosis
Molecular Function
- serine-type endopeptidase activity
- scavenger receptor activity
- protein binding
Cellular Component
- brush border
- membrane
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000284885
- Coding exons
- 25
- Length
- 216765
- Individuals with no LoFs
- 125287
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 459
- Defined
- 125747
- p
- 0.00183
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.860 | 582 | 526 | 1.11 | 0.0000264 | 6708 |
| Missense (PolyPhen) | 203 | 185.35 | 1.0952 | 2391 | ||
| Synonymous | -0.676 | 204 | 192 | 1.06 | 0.0000106 | 1885 |
| Loss of Function | 0.613 | 51 | 56.0 | 0.911 | 0.00000280 | 687 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00056 | 0.00055 | rare |
| Latino/Admixed American | 0.0028 | 0.0027 | notable |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00082 | 0.00082 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.0024 | 0.0023 | notable |
| South Asian | 0.0017 | 0.0015 | notable |
| Other | 0.0046 | 0.0046 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Responsible for initiating activation of pancreatic proteolytic proenzymes (trypsin, chymotrypsin and carboxypeptidase A). It catalyzes the conversion of trypsinogen to trypsin which in turn activates other proenzymes including chymotrypsinogen, procarboxypeptidases, and proelastases.;
- Disease
- DISEASE: Enterokinase deficiency (ENTKD) [MIM:226200]: Life- threatening intestinal malabsorption disorder characterized by diarrhea and failure to thrive. {ECO:0000269|PubMed:11719902}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.245
Intolerance Scores
- RVIS EVS
- 1.92
- RVIS percentile EVS
- 97.45
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.114
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | High | Medium | High |
| Cancer | High | High | High |